
    
      SIENA is a 42-week randomized, stratified, 3-period double-blind placebo-controlled crossover
      study of patients with symptomatic mild-to-moderate asthma, not already taking an inhaled
      corticosteroid, in whom the effect of "medium-dose" inhaled corticosteroid (ICS) will be
      compared with the effect of placebo and with a long-acting muscarinic antagonist (LMA).
    
  